Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: The Framingham Offspring Study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69 A, Issue 3, 2014, Pages 301-307

  Liu, Christine K ^a,b   Lyass, Asya ^c,d   Massaro, Joseph M ^c,e   D'Agostino Sr , Ralph B ^c,d   Fox, Caroline S ^c,f,g   Murabito, Joanne M ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d Boston University   (United States)

^e BOSTON UNIVERSITY   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic kidney disease; Cystatin C; Disability; Gait speed

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CST3 PROTEIN, HUMAN; CYSTATIN C;

AGE; AGED; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETES MELLITUS; DISABILITY; FEMALE; FOLLOW UP; GAIT; GAIT SPEED.; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; LOCOMOTION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MOTOR ACTIVITY; PHYSIOLOGY; PROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; WALKING; WALKING DIFFICULTY;

CHRONIC KIDNEY DISEASE; CYSTATIN C; DISABILITY; GAIT SPEED.;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; CYSTATIN C; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; GAIT; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; LOCOMOTION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOBILITY LIMITATION; MOTOR ACTIVITY; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; SELF REPORT; SEX FACTORS; WALKING;

EID: 84896800785     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt096     Document Type: Article

References (40)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047.
2. Administration on Aging. Profile of Older Americans: 2011. http://www.aoa.gov/aoaroot/aging-statistics/Profile/2011/4.aspx. Accessed on May 9, 2012.
3. Fried LF, Lee JS, Shlipak M, et al. Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc. 2006;54:750-756.
4. Bowling CB, Sawyer P, Campbell RC, Ahmed A, Allman RM. Impact of chronic kidney disease on activities of daily living in communitydwelling older adults. J Gerontol A Biol Sci Med Sci. 2011;66:689-694.
5. Shlipak MG, Stehman-Breen C, Fried LF, et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis. 2004;43:861-867.
6. Gallagher D, Visser M, De Meersman RE, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol. 1997;83:229-239.
7. Wasén E, Isoaho R, Mattila K, Vahlberg T, Kivelä SL, Irjala K. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Intern Med. 2004;256:70-78.
8. Inker LA, Schmid CH, Tighiouart H, et al.; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20-29.
9. Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92-100.
10. Levey AS, Coresh J, Balk E, et al.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147.
11. Gansevoort RT, Matsushita K, Van Der Velde M, et al.; Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93-104.
12. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073-2081.
13. Dalrymple LS, Katz R, Kestenbaum B, et al. The risk of infectionrelated hospitalization with decreased kidney function. Am J Kidney Dis. 2012;59:356-363.
14. Schöttker B, Herder C, Müller H, Brenner H, Rothenbacher D. Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes. Diabetes Care. 2012;35:879-886.
15. Abellan Van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people: an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009;13:881-889.
16. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study. Design and preliminary data. Prev Med. 1975;4:518-525.
17. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension. 2011;58:784-790.
18. Inker LA, Eckfeldt J, Levey AS, et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. 2011;58:682-684.
19. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920-929.
20. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
21. Rosow I, Breslau N. A Guttman health scale for the aged. J Gerontol. 1966;21:556-559.
22. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Bethesda, MD: National Institute on Aging; 1995.
23. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32:2575-2579.
24. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52:39-48.
25. Kannel WB, Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med. 1979;139:857-861.
26. Shastri S, Tighiouart H, Katz R, et al. Chronic kidney disease in octogenarians. Clin J Am Soc Nephrol. 2011;6:1410-1417.
27. Peralta CA, Katz R, Sarnak MJ, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol. 2011;22:147-155.
28. Sarnak MJ, Katz R, Fried LF, et al.; Cardiovascular Health Study. Cystatin C and aging success. Arch Intern Med. 2008;168:147-153.
29. Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol. 2009;20:2214-2222.
30. Abellan Van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13:708-712.
31. Odden MC, Chertow GM, Fried LF, et al.; HABC Study. Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol. 2006;164:1180-1189.
32. Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well-functioning older people-results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53:1675-1680.
33. Studenski SA, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305:50-58.
34. Reaich D, Price SR, England BK, Mitch WE. Mechanisms causing muscle loss in chronic renal failure. Am J Kidney Dis. 1995;26:242-247.
35. Dhesi JK, Bearne LM, Moniz C, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res. 2002;17:891-897.
36. Nickolas TL, Stein EM, Dworakowski E., et al. Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res. 2013;8:1811-1820.
37. Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52:719-724.
38. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305:1545-1552.
39. National Kidney Foundation. National Kidney Foundation Kidney Disease Outcomes Quality Initiative: 2002. http://www.kidney.org/professionals/KDOQI/ guidelines-ckd/p5-lab-g5.htm. Accessed on May 5, 2013.
40. Alexander NB, Guire KE, Thelen DG, et al. Self-reported walking ability predicts functional mobility performance in frail older adults. J Am Geriatr Soc. 2000;48:1408-1413.